How McClain was paid
$3.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Sean McClainPresident, Founder and Chief Executive Officer | $689,936 | $650,484 | $1,959,630 | $372,565 | $14,000 | $3,686,615 |
| Zachariah Jonasson, Ph.D.Chief Financial Officer and Chief Business Officer | $553,453 | $650,484 | $839,804 | $249,054 | $14,000 | $2,306,795 |
| Andreas Busch, Ph.D.Chief Innovation Officer | $712,797 | $81,054 | $239,422 | $384,910 | $142,954 | $1,561,137 |
What changed and why
- $9.8MCEO total compensation decreased from $9,786,988 in 2024 to $3,686,615 in 2025.
- 90%Corporate performance goals for the annual cash incentive bonus plan were achieved at 90% for 2025.
- Flagship program ABS-201 advanced from discovery to Phase 1/2a clinical trials in 2025.
- Dr. Andreas Busch retired from his position as Chief Innovation Officer effective March 31, 2026.
- Aon's Human Capital Solutions practice served as the independent external compensation consultant.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.